Novo Nordisk veteran takes up CMO position at Danish-Swedish biotech company
Anders Dyhr Toft, who has worked for Novo Nordisk for many years, will step into the role of CMO at SynAct Pharma on Aug. 1.
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN
On Wednesday, SynAct Pharma appointed Anders Dyhr Toft as its Chief Medical Officer (CMO). This will come into effect on Aug. 1, according to a company press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk launches smart insulin pen in Denmark
For subscribers
